Kedrab: 1st pediatric trial for Human Rabies Immune Globulin
Outbreak News2 Sep 2020

Kedrab: 1st pediatric trial for Human Rabies Immune Globulin

Rabies post exposure prophylaxis, or PEP, consists of a rabies vaccine series and human rabies immune globulin (HRIG).

Kedrion Biopharma's human rabies immune globulin, Kedrab, was FDA approved in 2017. And now for the first time, the safety of HRIG (Kedrab) was studied in children.

Joining me today to discuss rabies, PEP and the pediatric trial is James Linakis, MD, PhD. Dr. Linakis is Professor of Emergency Medicine and Pediatrics at Brown Medical School and Associate Director of Pediatric Emergency Medicine at Rhode Island Hospital's Hasbro Children's Hospital.

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(535)

Populärt inom Politik & nyheter

svenska-fall
motiv
aftonbladet-krim
p3-krim
spar
aftonbladet-daily
flashback-forever
rss-sanning-konsekvens
rss-expressen-dok
rss-krimreportrarna
rss-vad-fan-hande
svd-ledarredaktionen
rss-frandfors-horna
rss-flodet
rss-aftonbladet-krim
politiken
dagens-eko
spotlight
olyckan-inifran
rss-krimstad